The science behind EVEBRA

How can gentle tension change tissue?

EVEBRA is designed around external tissue expansion: a sustained, low-level vacuum that gently draws breast tissue outward over many hours. The approach grew from Dr. Roger Khouri’s research with an earlier system, BRAVA.

About 12 hours of daily wear · 4–6 month recommended protocol · Individual results vary

Research MRI from the earlier external expansion method. This is not a clinical trial of today’s EVEBRA device.

01 / The underlying principle

Tissue responds to a sustained stretch.

When a gentle mechanical force is maintained, cells sense that force and the surrounding tissue can adapt. This response is called mechanotransduction. Tissue expansion has been studied across medical fields, including skin expansion and bone distraction.

EVEBRA applies a controlled vacuum through wearable domes. Its goal is gradual breast enlargement using the body’s own tissue response, without surgery or implants. Short bursts of suction can create temporary swelling; sustained wear is the key distinction in the external expansion research.

The research connectionPublished breast studies on this page evaluated BRAVA and other earlier external expansion systems. EVEBRA builds on that method; their findings are not a measured outcome for every EVEBRA user.

The biological pathway

From a mechanical signal to tissue adaptation.

The original page’s two medical illustrations and eight scientific notes are kept here, with plain-language context.

Original EVEBRA medical illustration of three breast cross-sections under outward tension
Original EVEBRA illustration · outward mechanical tension
01

Mechanical distraction

A regulated vacuum gently draws tissue outward. The first response includes temporary stretch and fluid change.

02

Mechanotransduction

Cells detect the sustained force and respond through signaling pathways. This is the central biological principle behind tissue expansion.

03

Fibroblasts and structure

Fibroblasts help make collagen and the extracellular matrix that supports tissue structure during adaptation.

04

New blood vessels

Angiogenesis helps provide oxygen and nutrients as tissue changes. The response is gradual and varies by person.

05

Remodeling over time

With consistent tension, cells and their surrounding matrix can adapt. A single short wear session is different from a months-long protocol.

Original EVEBRA illustration of tissue expansion with fat cells and blood vessels
Original EVEBRA illustration · tissue-level response

Biological and clinical outcomes

What the studies actually observed.

At the cellular level, mechanical expansion has been studied for its effects on cell activity, matrix remodeling and blood vessel formation. At the tissue level, temporary swelling can recede after wear stops.

In Khouri et al. (2000), 17 women enrolled and 12 completed an earlier external expansion protocol. MRI showed proportional enlargement of adipose and fibroglandular tissue without edema at the measured follow-up. Some early volume receded after stopping; the study reported no significant further reduction during follow-up of up to 30 weeks. It was a small study without a control group, and individual outcomes varied.

02 / What to expect

A gradual process, shown in four stages.

These original EVEBRA illustrations explain the proposed process. Week labels are illustrative, not a timetable or promise of a particular result.

Original EVEBRA stage one illustration showing baseline breast tissue
Before EVEBRA

Baseline

The original inset depicts glandular tissue and fat lobules before the wear protocol begins.

Original EVEBRA stage two illustration showing early outward tissue expansion
Illustrated weeks 0–8

Early response

Vacuum gently draws the tissue outward. Early visible fullness can include temporary swelling.

Original EVEBRA stage three illustration showing later tissue adaptation
Illustrated weeks 10–20

Continued adaptation

Sustained daily tension is intended to support gradual tissue expansion. Timing and degree of change vary.

Original EVEBRA stage four illustration showing tissue after completing an external expansion protocol
After stopping

What remains

Temporary fullness may recede. Earlier-system research used MRI to assess tissue change after this settling period. Retention varies.

03 / The daily commitment

The difference between a short swell and a sustained routine.

EVEBRA’s recommended protocol is about 12 hours of daily wear for 4–6 months. Many people wear it overnight.

Original EVEBRA pump-off and pump-on diagram showing tissue drawn into a clear dome
Original EVEBRA illustration · pump off versus pump on

The “Cinderella effect”

Immediate fullness is not the whole story.

Short-term vacuum can create visible fullness from a temporary fluid response. The original page calls this the “Cinderella effect.” That appearance can settle after the device is removed.

Published research on the earlier external expansion method studied prolonged, repeated wear and used MRI to distinguish measured tissue change from fluid alone. A consistent pattern matters more than judging a single day’s appearance.

See if the routine fits your life
Original EVEBRA graph contrasting visible fullness during wear with a slower illustrative baseline
Original daily-expectations diagram. The lines illustrate temporary fullness and a slower possible tissue response; they are not measured individual results.

Wear-time illustrations

Why consistency matters.

The four charts from the current page are retained as conceptual examples. Their percentages and curves should not be read as validated thresholds or personal forecasts.

Original EVEBRA illustrative 50 percent wear-time graph
About half the dayThe page’s reference pattern for about 12 hours of daily wear.
Original EVEBRA illustrative 40 percent wear-time graph
Less daily wearUse this drawing to understand how a shorter routine may reduce the time under tension.
Original EVEBRA illustrative 60 percent wear-time graph
More daily wearMore time under tension is shown conceptually. It does not promise faster growth.
Original EVEBRA illustrative missed-day wear graph
A missed dayOne missed day does not automatically undo prior wear. Return to the routine when practical.

04 / Read the evidence

The published work behind the method.

These publications concern BRAVA or earlier external expansion systems. Read the findings, study designs and limitations before applying them to EVEBRA.

First page of Khouri et al. 2000 publication
2000 · Peer-reviewed study

Nonsurgical Breast Enlargement Using an External Soft-Tissue Expansion System

Khouri RK, Schlenz I, Murphy BJ, Baker TJ. Plastic and Reconstructive Surgery. 105(7):2500–2512. Seventeen enrolled; twelve completed the single-group protocol.

Read the paper
First page of Schlenz and Kaider 2007 publication
2007 · Clinical follow-up

The Brava External Tissue Expander: Is Breast Enlargement Without Surgery a Reality?

Schlenz I, Kaider A. Plastic and Reconstructive Surgery. 120(6):1680–1689. Fifty women began; forty were evaluated after treatment. Wear intensity was associated with outcomes.

Read the paper
First page of 2002 ASPS meeting abstract on BRAVA external expansion
2002 · Conference abstract

Multi-center Evaluation of an External Tissue Expander System (Brava) for Breast Enlargement

Khouri RK et al. Presented at the American Society of Plastic Surgeons. A conference abstract is a different level of detail from a full peer-reviewed paper.

See all publications

The studies above investigated earlier devices and protocols. They do not guarantee an EVEBRA result. Individual results depend on fit, consistent use and personal biology.

Hear it from the inventor

Dr. Khouri explains tension-induced tissue growth.

Watch the original whiteboard explanation from Dr. Roger Khouri, inventor of BRAVA and EVEBRA.

Meet Dr. Khouri

Ready to look closer?

Understand the science. Then decide if the routine is right for you.

Review candidacy, fit and the current product details before ordering.

October Fall Event

$1,799 $2,499

Save $700 with code FALL700 and get a free pump carrying bag with your device. Ends October 31 at 11:59 pm ET.

View EVEBRA with FALL700